The integration of D360 and Design Hub transforms drug discovery by optimizing the Design-Make-Test-Analyze (DMTA) cycle. This integration eliminates manual inefficiencies, allowing researchers to focus on scientific innovation. By uniting data access, analysis, and compound design workflows, D360 and Design Hub empower discovery research teams to make faster, informed decisions and seamlessly track research progress.
D360 and Design Hub Integration
Connecting data analysis with compound design to close the DMTA loop and accelerate drug discovery
Learn more about D360 and Design Hub Integration
Better together: close the informatics gap between data analysis-compound design-synthesis with D360-Design Hub integration
Improve the efficiency of the drug discovery process with D360 and Design Hub
The integration of D360 and Chemaxon Design Hub allows scientists to apply design criteria found from data analysis to scientific hypothesis and candidate compounds in Design Hub. The ability to readily turn knowledge into action completes the digitization of the DMTA cycle and allows capture and management of knowledge that is otherwise lost in PowerPoint slides.
How research teams benefit
関連製品
なぜサターラが選ばれるのか
Certara delivers cutting-edge solutions that empower researchers to accelerate drug discovery and improve decision-making.
- 初期創薬は、サターラの中核となる専門領域であり、この領域で豊富な実績と高い評価を持つエキスパートチームが支えています。
- Certara’s drug discovery software solutions are widely recognized and accepted by industry leaders.
"D360のおかげで、年間でデータ解析に費やす時間を数百時間も削減することができました。D360 は当社の研究を支える重要な基盤となっています。サターラの専門家チームは、粘り強く、柔軟な対応力を持っていて、常に解決策を提案してくれます。我々は成功に繋がる強固なパートナーシップを築くことができました。

Dr. Keith Hornberger
Arvinas社 化学部門ディレクター
関連情報
全て見るデモのご相談
Discover how D360 and Chemaxon Design Hub integration can transform your drug discovery workflows.